Literature DB >> 31041278

An association of Helicobacter pylori infection with endoscopic and histological findings in the Nepalese population.

Amrendra Kumar Mandal1, Paritosh Kafle1, Pradeep Puri1, Baikuntha Chaulagai1, Jasdeep S Sidhu1, Muhammad Hassan1, Mukesh S Paudel2, Rajan Kanth3, Vijay Gayam1.   

Abstract

BACKGROUND: Helicobacter pylori (H. pylori) is one of the most common human infections worldwide particularly in the developing countries. We aimed to study an association of H. Pylori infection with endoscopic and histological findings in the Nepalese population.
MATERIALS AND METHODS: We conducted a study between Oct 2014 and Jan 2015 after meeting inclusion and exclusion criteria. Institutional Review Board approval was obtained from National Academy of Medical Sciences. Endoscopic findings and histopathological diagnosis were documented and data were analysed.
RESULTS: A total of 113 patients who had complete endoscopy were enrolled. The prevalence of H. pylori infections recorded was 27 (23.9%) patients. There were 17 (62%) male and 10 (37%) female infected with H. pylori (P = 0.33). All biopsied specimens were sent to pathology lab for examination. The most common endoscopic findings was erythematous antral gastritis (40.7%) followed by erosive gastritis 34 (30.1%), pangastritis 10 (8.8%), duodenal ulcer 13 (11.5%), gastric ulcer 9 (8%), erosive fundal gastritis 2 (1.8%), reflux esophagitis 10 (37%) (P < 0.04). Histology revealed that 23 (85.2%) patients had chronic active gastritis (CAG); (P < 0.001).
CONCLUSIONS: Our study revealed that H. pylori infection is strongly associated with chronic active gastritis (CAG) and Reflux esophagitis in Nepalese adults.

Entities:  

Keywords:  Chronic active gastritis; Helicobacterpylori; dyspepsia

Year:  2019        PMID: 31041278      PMCID: PMC6482781          DOI: 10.4103/jfmpc.jfmpc_82_19

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


Introduction

H. pylori, is a Gram-negative pathogen that chronically infects at least 50% of the world's population; its annual incidence is more in developing countries in comparison to developed countries.[1] In developing countries, more than 80% of the population is H. pylori positive.[2] The strong association of H. pylori with dyspepsia has caused a drastic change in the patient management.[3] Esophagogastroduodenoscopy (EGD) is usually performed due to persistent dyspeptic symptoms and/or presence of alarming symptoms for organic lesion. The vast majority of infections despite asymptomatic; have histological evidence of gastritis. The literature shows that H. pylori is associated with superficial chronic active gastritis, characterized by neutrophils in addition to lymphocytes and plasma cells.[4] Documented risk factors for H. pylori include low socioeconomic status, overcrowding, poor sanitation or hygiene, and living in a developing countries.[5]

Materials and Methods

This was a cross sectional study carried out at National Academy of Medical Sciences (NAMS) from Oct 2014 to Jan 2015. The study was approved by Institutional Review Board (IRB) of NAMS. We included patients who were age 18 years and/or older who presented to Gastroenterology outpatient clinic at NAMS, Bir hospital with symptoms of dyspepsia. An informed written consent was taken from all participants. Demographic data was collected in a questionnaire prepared for the study. We have excluded patients who did not give consent for study, on histamine-2 receptor blockers, sucralfate and non-steroidal anti-inflammatory drugs, who had severe co-morbid conditions including respiratory disorders, recent MI, shock, patients with upper gastrointestinal bleeding, history of partial gastric resection, and normal EGD finding. An upper gastrointestinal endoscopic examination was performed with a FUJINON scope after an overnight fasting and stopping PPI for 4 weeks. EGD was performed by an expert endoscopist. A biopsy was taken from antrum, body and fundus preserved in formalin and sent for histopathological analysis. Sections were stained with routine Haematoxylin and Eosin for detection of H. pylori and gastritis. Giemsa stain was also used for better yield of H. pylori infection. Slides were examined microscopically for H. pylori by the Pathologist. Presence of H. pylori was regarded as positive while absence was regarded as negative. A histopathological finding of chronic active gastritis was also noted. All data were entered in Microsoft EXCEL and analyzed by SPSS 16 (Statistical Package for Social Sciences) software. Continuous data were expressed as mean and standard deviation whereas categorical data were expressed as number (percentage). Continuous data were analyzed using t-test and categorical data were analyzed using Chi-square test.

Results

Among the 113 participants who underwent EGD, there were 62 male and 51 female; mean age of the patients was 36.4 years with age ranging between 16 and 88 years. Seventeen patients were excluded from the study due to presence of normal findings on EGD. All patients underwent EGD and simultaneous biopsy for detection of presence or absence of H. pylori based on histopathological studies. The flow chart of the study population is shown in Figure 1.
Figure 1

Showing flow chart of the study populations

Showing flow chart of the study populations Of 27 (23.9%) patients infected by H. pylori; 17 (63%) were male and 10 (37%) were female. The infection by H. pylori did not differ significantly between males and females (P = 0.33). The age and sex of the patient cohort are shown in Table 1. Most of the patients presented with the symptoms of burning abdominal sensation, additionally the symptoms were not statistically different among the H. pylori positive and H. pylori negative group as shown in Table 2.
Table 1

Age and sex distribution of the study population

CharacteristicsAll patients (n=113)H. Pylori (+) (n=27)H. Pylori (-) (n=86)P
Age, mean years (%)36.4 (16-88)38.1 (18-71)35.9 (16-88)0.460
Age group
 < 65110 (97.3)25 (92.6)85 (98.8)0.782
 > 653 (2.7)2 (7.4)1 (1.2)
Sex
 Male62 (54.9)17 (63.0)45 (52.3)0.333
 Female51 (45.1)10 (37.0)41 (47.7)
Table 2

Spectrum of Clinical manifestation of the study population

Clinical manifestationAll Patients (n=113)H. Pylori (+) (n=27)H. Pylori (-) (n=86)P
Bloating n (%)39 (34.5)13 (48.1)26 (30.2)0.086
Belching n (%)36 (31.8)9 (33.3)27 (31.4)0.850
Regurgitation n (%)30 (26.5)9 (33.3)21 (24.4)0.360
Burning n (%) Sensation65 (57.5)18 (66.7)47 (54.7)0.271
Nausea n (%)36 (31.9)11 (40.1)25 (29.1)0.256
Vomiting n (%)11 (9.7)4 (14.8)7 (8.1)0.307
Age and sex distribution of the study population Spectrum of Clinical manifestation of the study population The most common endoscopic findings was erythematous antral gastritis (40.7%) followed by erosive gastritis 34 (30.1%), pangastritis 10 (8.8%), duodenal ulcer 13 (11.5%), gastric ulcer 9 (8%) and erosive fundal gastritis 2 (1.8%) were detected. The endoscopic findings such as gastritis, gastric ulcer, duodenal ulcer were not significantly associated with H. pylori. Ten (37%) reflux esophagitis patients were H. pylori infected [Table 3].
Table 3

Esophagogastroduodenoscopy (EGD) findings of the patients

EGD findingsAll Patients (n=113)H. Pylori (+) (n=27)H. Pylori (-) (n=86)P
Erythematous Antral Gastritis n (%)46 (40.7)8 (29.6)38 (44.2)0.179
Reflux Esophagitis n (%)26 (23.0)10 (37.0)16 (18.6)0.047
Erosive Gastritis n (%)34 (30.1)9 (33.3)25 (29.1)0.673
Pangastritis n (%)10 (8.8)2 (7.4)8 (9.3)0.762
Gastric Ulcer n (%)9 (8.0)4 (14.8)5 (5.8)0.132
Duodenal Ulcer n (%)13 (11.5)5 (18.5)8 (9.3)0.190
Erosive Fundal Gastritis n (%)2 (1.8)1 (3.7)1 (1.2)0.382
Esophagogastroduodenoscopy (EGD) findings of the patients A histopathological finding of chronic active gastritis (CAG) was observed in H. pylori infection. Patients who had H. pylori had significantly higher CAG (85.2%) as compared to H. pylori negative subjects (P < 0.001). The histopathological findings of the study patients undergoing EGD are shown in Table 4.
Table 4

Histopathological examination (HPE) findings

HPE findingsAll Patients (n=113)H. Pylori (+) (n=27)H. Pylori (-) (n=86)P
Gastric Carcinoma n (%)3 (2.7)1 (3.7)2 (2.3)0.700
Chronic Active Gastritis n (%)46 (40.7)23 (85.2)23 (26.7)<0.001
Metaplasia n (%)11 (9.7)4 (14.8)7 (8.1)0.307
Histopathological examination (HPE) findings

Discussion

In our study, we documented the H. pylori infection of 23.9% which is in accordance with the report of 29.5% and 29.4% from the studies done by Rai et al. and Shrestha et al. respectively from Nepal.[6] The other studies from Nepal, however revealed the prevalence ranging between 16.3 and 70.5%.[789101112] H. pylori is a major pathogen of the gastrointestinal tract and it has been linked to a wide spectrum of gastric disorders, including gastritis, peptic ulcer, gastric cancer, and mucosa-associated lymphoid tissue lymphoma.[1314] However, the infection remains latent in the majority of infected patients, and only few of them with H. pylori infection develop the disease and its complications.[15] Makaju et al. in a dyspeptic patient observed a prevalence of 33.9%, which is slightly higher as compared to our study, however their study was a decade older and current prevalence might be decreased due to excellent diagnostic modality resulting in earlier treatment as well as empirical therapy in our populations.[11] A study from Turkey by Ceylan et al. also observed a very similar prevalence of 23.6% similar to present study.[16] These data indicates that currently the prevalence of H. pylori infections in developing nations may not be very high as was reflected from some of the older studies. A significantly higher rate of infection in an urban population (78.8%) than in a rural population (69.2%), have been reported by Kawasaki et al. from Nepal.[1718] The prevalence of H. pylori infection varies between different countries, as well as different geographic area within the same country. It had shown that age and socioeconomic status of the patients also plays a significant role in infection.[19] Our study is also consistent with Shrestha et al., Fraser et al. and Begue et al. findings without any difference in age and gender of H. pylori infection.[62021] A significant proportion of patients (37%) presenting with dyspepsia had reflux esophagitis in our study which is higher than Song et al. study (18.8%) from Korea[22] The higher prevalence in our study could be attributed to majority of patients with gastritis linked to antral parts of the stomach resulting in excess of acid secretion. However, we did not stratify the reflux esophagitis as per Los Angeles classification in our study, but a study from our same hospital (NAMS) by Kasyap et al., reported grades of esophagitis as follows: grade A 31.8%, grade B 39.4%, grade C 33.8% and grade D 4.9%.[23] In our study, CAG was significantly associated with the presence of H. pylori infection. Our finding of histo-pathological association with H. pylori infections is also consistent with two other studies from Nepal by Dhakhwa et al. and Thapa et al., as well as very similar results by Schultz et al., who showed 87% cases had chronic active gastritis observed in H. pylori infected person.[6824] As H. pylori infection is very common;[12] especially in the developing nations; patients with symptoms of dyspepsia tend to visit the family physicians or primary care doctors and are subsequently referred to the specialist in case of H. pylori complications such as hematemesis, gastric cancer etc., Hence, the knowledge and awareness of this infection is equally important in general practice. Also we did not use the special stains for H. pylori detection keeping in mind of its limitations in the resource limited settings like ours. Unfortunately, poor patients cannot afford to pay for the multiple H. pylori tests such as stool for antigen test or urea breath test in order to confirm the diagnosis. In this situation, the histological evidence of CAG alone based on hematoxylin and eosin (H and E) and Giemsa stain may be used to treat H. pylori infections regardless of H. pylori seen histologically.[824] This finding is also supported by our study and CAG may be used as a surrogate marker of H pylori infections. Due to the use of over the counter antibiotics; the resistance of H pylori has been increasing for Clarithromycin and Metronidazole. So, the updated guidelines for the treatment of this infection are pivotal in reducing the emerging marcolide resistance. The American college of Gastroenterology (ACG) guideline and the Toronto Consensus (2016) advocate for a longer duration of treatment (14 days for almost all regimens).[2526] Either the Bismuth based quadruple therapy or the use of sequential treatment as a first-line therapy has been endorsed by these guidelines. Patients should be asked about their previous exposure of antibiotic and this information should be bear in mind for the decision-making process while choosing a treatment regimen for H. pylori.

Conclusions

Reflux esophagitis and CAG are commonly associated with H. pylori infections and the observations of CAG alone in a patient undergoing EGD for dyspepsia may be treated with anti- H. pylori therapy without further evidence of H. pylori infection, especially in the resource limited settings.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  24 in total

Review 1.  Helicobacter pylori infection.

Authors:  Sebastian Suerbaum; Pierre Michetti
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

Review 2.  Inflammation, atrophy, and gastric cancer.

Authors:  James G Fox; Timothy C Wang
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

Review 3.  Helicobacter pylori: epidemiology and routes of transmission.

Authors:  L M Brown
Journal:  Epidemiol Rev       Date:  2000       Impact factor: 6.222

4.  Prevalence of Helicobacter pylori in Dhulikhel Hospital, Kathmandu University Teaching Hospital: a retrospective histopathologic study.

Authors:  R K Makaju; M D Tamang; Y Sharma; N Sharma; R Koju; M Ashraf
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2005 Oct-Dec

Review 5.  Pathogenesis of Helicobacter pylori infection.

Authors:  Johannes G Kusters; Arnoud H M van Vliet; Ernst J Kuipers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

6.  Seroprevalence of Helicobacter pylori infection in urban and rural Vietnam.

Authors:  Thi Thu Ha Hoang; Carina Bengtsson; Dac Cam Phung; Mikael Sörberg; Marta Granström
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

7.  Endoscopic reflux esophagitis in patients with upper abdominal pain-predominant dyspepsia.

Authors:  Ho June Song; Kee Don Choi; Hwoon-Yong Jung; Gin Hyug Lee; Ji Yun Jo; Jeong-Sik Byeon; Suk-Kyun Yang; Weon-Seon Hong; Jin-Ho Kim
Journal:  J Gastroenterol Hepatol       Date:  2007-12       Impact factor: 4.029

8.  Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: the age, gender and endoscopic diagnosis matched study.

Authors:  T Matsuhisa; M Miki; N Yamada; S K Sharma; B M Shrestha
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2007 Jul-Sep

9.  Transient and persistent Helicobacter pylori colonization in Native American children.

Authors:  Guillermo I Pérez-Pérez; R Bradley Sack; Raymond Reid; Mathuram Santosham; Janne Croll; Martin J Blaser
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Prevalence of Helicobacter pylori in children and their family members in a district in Turkey.

Authors:  Abdullah Ceylan; Ercan Kirimi; Oğuz Tuncer; Kürşat Türkdoğan; Sevil Ariyuca; Nesrin Ceylan
Journal:  J Health Popul Nutr       Date:  2007-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.